Diabetes Medicines in India: Imported Tablets and Weekly Injections for Type 2 Diabetes
The main forms of diabetes, and which ones this page covers
Doctors sort diabetes by its cause, because the cause decides the treatment. Every medicine listed here carries an approval for type 2 diabetes in adults or, in one case, for nerve pain that diabetes has caused.
| Form | What is going on | How it is usually treated | On this page? |
|---|---|---|---|
| Type 2 diabetes | The body resists its own insulin and, over the years, the pancreas cannot keep up | Diet, activity and weight control first, then tablets and injections added step by step; some people later need insulin | Yes, all the sugar-lowering medicines below |
| Type 1 diabetes | The pancreas makes little or no insulin | Insulin every day, as the WHO notes [5] | No; none of these medicines is approved for type 1 |
| Prediabetes | Sugar is above normal but below the diabetes cut-off | Lifestyle change and regular testing | No |
| Diabetic nerve pain | Long-standing high sugar damages the nerves of the feet and legs | Pain-relief medicines alongside tighter sugar control and foot care | Yes, one capsule approved in China |
Gestational diabetes, which appears in pregnancy, is managed by the obstetric and diabetes team and is not covered here.
What large Indian studies show
- More common than earlier estimates. Between 2008 and 2020, ICMR-INDIAB took blood samples from adults in villages and towns of every state and union territory surveyed, 31 in all along with Delhi. Diabetes was more frequent in towns and cities than in villages, and in a number of the poorer states (those lower on the human development index) prediabetes was more common than diabetes itself, a sign that numbers there are still climbing [1].
- Few people reach their targets. Among 5,789 adults who already knew they had diabetes, only 36.3% had an HbA1c under 7%, 48.8% had their blood pressure in range and 41.5% had LDL cholesterol in range. Just 16.7% checked their own sugar at home, and even among insulin users the figure was 36.9% [2].
- Control improves slowly even with treatment. The LANDMARC study followed 6,234 people with type 2 diabetes in cities and smaller towns for three years. Their average HbA1c at the start was 8.1%. The share with an HbA1c under 7% rose from 25.1% at the start to 36.6% after three years, and insulin use went up from 25.5% to 36.7% over the same period [6, 7].
- Nerve damage leads the complications. In LANDMARC, neuropathy made up 82.0% of the small-vessel complications reported over three years [6]. A rural South Indian study found that 61% of its patients had a burning feeling in the feet and 36.9% had numbness [4].
- Eye damage often goes unnoticed. In SMART India, 7,910 of 42,146 people aged 40 and over (18.8%) turned out to have diabetes, and 1,783 of the 6,133 with readable retinal photos did not know it beforehand. The authors estimate that about 3 million Indians aged 40 or more have sight-threatening diabetic retinopathy [3].
How the imported medicines lower blood sugar
LANDMARC showed that metformin (a biguanide), sulfonylureas and DPP-4 inhibitors are the tablets Indian doctors already use most; DPP-4 use rose from 48.9% to 61.2% of patients in two years [6, 7]. The medicines on this page belong to the same broad families or to newer ones, but each is a molecule or a combination that is not on the Indian market. Your doctor chooses by HbA1c, weight, kidney function, heart risk and how many tablets you can manage.
| Group | What it does in the body | Medicines here |
|---|---|---|
| Weekly incretin injections | Copy gut hormones released after a meal: more insulin when sugar is high, slower stomach emptying, less appetite | Mounjaro (GIP + GLP-1), Mazdutide (GLP-1 + glucagon), Ecnoglutide and Visepegenatide (GLP-1) |
| DPP-4 inhibitor tablets | Stop an enzyme from breaking down those same gut hormones, so the body's own supply lasts longer | Fotagliptin, Prusogliptin, Retagliptin, Cetagliptin, and Cofrogliptin (one tablet every two weeks) |
| SGLT2 inhibitor tablet | Make the kidneys pass surplus glucose out in the urine | Ganagliflozin |
| Fixed-dose combinations | Two or three of the above actions with metformin in a single tablet | Retagliptin + metformin; henagliflozin + retagliptin + metformin |
| Nerve pain capsule | Calms overactive pain nerves through the alpha-2-delta part of calcium channels | Crisugabalin |
Two points stand out for patients. Visepegenatide is started at its full weekly dose with no build-up period, and Mazdutide was the first medicine approved anywhere to act on both the GLP-1 and glucagon receptors.
Imported diabetes medicines by type
All 13 medicines below are prescription-only. Tap a type to filter. Each card opens the full medicine page with dosage, storage and safety details.













Compare all 13 diabetes medicines
| Medicine | Generic name | Diabetes type | Form | Approved by |
|---|---|---|---|---|
| Mounjaro | tirzepatide | Weekly injection | Pre-filled pen | US FDA |
| Mazdutide | mazdutide | Weekly injection | Pre-filled pen | China NMPA |
| Ecnoglutide | ecnoglutide | Weekly injection | Pre-filled pen | China NMPA |
| Visepegenatide | visepegenatide | Weekly injection | Pre-filled pen | China NMPA |
| Fotagliptin | fotagliptin benzoate | DPP-4 tablet | Tablet | China NMPA |
| Prusogliptin | prusogliptin | DPP-4 tablet | Tablet | China NMPA |
| Retagliptin | retagliptin phosphate | DPP-4 tablet | Tablet | China NMPA |
| Cetagliptin | cetagliptin phosphate | DPP-4 tablet | Tablet | China NMPA |
| Cofrogliptin | cofrogliptin | DPP-4 tablet | Tablet | China NMPA |
| Ganagliflozin | ganagliflozin (janagliflozin) | SGLT2 tablet | Tablet | China NMPA |
| Retagliptin And Metformin | retagliptin + metformin | Combination tablet, DPP-4 tablet | Tablet | China NMPA |
| Henagliflozin, Retagliptin And Metformin | henagliflozin + retagliptin + metformin | Combination tablet, SGLT2 tablet, DPP-4 tablet | Extended-release tablet | China NMPA |
| Crisugabalin | crisugabalin besilate | Diabetic nerve pain | Capsule | China NMPA |
Reports and checks your doctor will look at first
| Report or check | Why it matters | Most relevant to |
|---|---|---|
| HbA1c with fasting and after-meal sugar | Shows how far above target you are and whether one more medicine or a stronger change is needed | All sugar-lowering medicines here |
| Kidney function (creatinine and eGFR) | Our drug pages note that Ganagliflozin needs a kidney check before the first dose and at intervals, and that metformin is not used once eGFR falls below 30 | Ganagliflozin, both combination tablets |
| Personal and family thyroid history | The Mounjaro label has a boxed warning on thyroid C-cell tumours seen in rats; it is not given to anyone who has had medullary thyroid cancer, has a close relative who had it, or has MEN 2 | Mounjaro |
| Past pancreatitis | Pancreatitis has been reported with GLP-1 based injections; the Mounjaro label says to stop if it is suspected | Weekly injections |
| Retina check | The Mounjaro label lists diabetic retinopathy complications in people who already have retinopathy, and SMART India shows how often it is missed [3] | Weekly injections, and everyone with diabetes |
| Foot examination with a 10-g monofilament | A quick bedside test for loss of feeling, used in the rural South Indian study [4] | Crisugabalin, and everyone with diabetes |
| List of all current medicines | Low sugar is more likely when a new medicine is added to insulin or a sulfonylurea, so those doses may need to come down | All medicines here |
Getting the import permit, keeping pens cold, and planning the cost
Diabetes medicines are taken for years, so it helps to sort out the paperwork once. CDSCO grants the import permit to the patient: the application on Form 12A goes in under the patient's name, our pharmacist puts the file together, and the permit comes back as Form 12B. Our Form 12A and 12B page lists what is needed.
Tablets and capsules travel at ordinary room conditions as their packs allow. Injection pens are different: the US label says Mounjaro pens are stored cold, between 2 °C and 8 °C, and must never be frozen, and our Mazdutide page gives the same range. Pens like these are sent with a temperature logger under our hospital delivery process, so the hospital pharmacy can see the cold chain held all the way.
Because treatment is long term, ask about support schemes before you start. Company programmes, government schemes and charities are covered on our patient support page.
How to get these diabetes medicines in India
Prescription
Your doctor prescribes the medicine.
Share documents
Send the prescription and latest reports through Online Order.
Import paperwork
Our team checks the source and the import permissions.
Delivery
Delivered with the right storage, including cold chain.
Read How to Order and Indian import regulations. We also serve patients in Delhi NCR, Bangalore, Chennai, Mumbai, Kolkata, Hyderabad and Pune.
Has your doctor prescribed one of these medicines?
Share the prescription and we will guide you on availability and next steps.
Read more about diabetes
References
- Anjana RM et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474-489. https://pubmed.ncbi.nlm.nih.gov/37301218/
- Anjana RM et al. Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13). Lancet Diabetes Endocrinol. 2022;10(6):430-441. https://pubmed.ncbi.nlm.nih.gov/35461575/
- Raman R et al. Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban-rural locations, and socioeconomic indices: results from the SMART India study. Lancet Glob Health. 2022;10(12):e1764-e1773. https://pubmed.ncbi.nlm.nih.gov/36327997/
- Darivemula S et al. Prevalence and its associated determinants of diabetic peripheral neuropathy in individuals having type-2 diabetes mellitus in rural South India. Indian J Community Med. 2019;44(2):88-91. https://pubmed.ncbi.nlm.nih.gov/31333282/
- World Health Organization. Diabetes – fact sheet. https://www.who.int/news-room/fact-sheets/detail/diabetes
- Das AK et al. The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial). Endocrinol Diabetes Metab. 2023;6(5):e422. https://pubmed.ncbi.nlm.nih.gov/37392036/
- Das AK et al. Two-year trends from the LANDMARC study in patients with type 2 diabetes mellitus. Endocrinol Diabetes Metab. 2023;6(2):e404. https://pubmed.ncbi.nlm.nih.gov/36722454/
- US FDA prescribing information for Mounjaro (DailyMed). https://dailymed.nlm.nih.gov/dailymed/
This page gives general information only and does not replace medical advice. All medicines listed are prescription-only and must be used under a qualified doctor.